These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
99 related items for PubMed ID: 18289212
41. Insulin resistance among patients with chronic hepatitis C: etiology and impact on treatment. Harrison SA. Clin Gastroenterol Hepatol; 2008 Aug; 6(8):864-76. PubMed ID: 18585970 [Abstract] [Full Text] [Related]
42. [The oral glucose tolerance test in 1247 medical students]. López de Castillo S, Pisanty J. Salud Publica Mex; 1985 Aug; 27(4):322-31. PubMed ID: 4071281 [No Abstract] [Full Text] [Related]
43. Anti-oxidized low-density lipoprotein antibody levels are associated with the development of type 2 diabetes mellitus. Garrido-Sánchez L, Cardona F, García-Fuentes E, Rojo-Martínez G, Gómez-Zumaquero JM, Picón MJ, Soriguer F, Tinahones FJ. Eur J Clin Invest; 2008 Sep; 38(9):615-21. PubMed ID: 18837736 [Abstract] [Full Text] [Related]
44. Supplementation of hydrogen-rich water improves lipid and glucose metabolism in patients with type 2 diabetes or impaired glucose tolerance. Kajiyama S, Hasegawa G, Asano M, Hosoda H, Fukui M, Nakamura N, Kitawaki J, Imai S, Nakano K, Ohta M, Adachi T, Obayashi H, Yoshikawa T. Nutr Res; 2008 Mar; 28(3):137-43. PubMed ID: 19083400 [Abstract] [Full Text] [Related]
45. Prevalence of diabetes mellitus and other abnormalities of glucose tolerance in young adults aged 20-40 years in North India (Kashmir Valley). Zargar AH, Wani AA, Laway BA, Masoodi SR, Wani AI, Bashir MI, Dar FA. Diabetes Res Clin Pract; 2008 Nov; 82(2):276-81. PubMed ID: 18814927 [Abstract] [Full Text] [Related]
47. Eradication of hepatitis C virus by interferon improves whole-body insulin resistance and hyperinsulinaemia in patients with chronic hepatitis C. Kawaguchi Y, Mizuta T, Oza N, Takahashi H, Ario K, Yoshimura T, Eguchi Y, Ozaki I, Hisatomi A, Fujimoto K. Liver Int; 2009 Jul; 29(6):871-7. PubMed ID: 19302179 [Abstract] [Full Text] [Related]
50. Leptin: a predictor of abnormal glucose tolerance and prognosis in patients with myocardial infarction and without previously known Type 2 diabetes. Wallander M, Söderberg S, Norhammar A. Diabet Med; 2008 Aug; 25(8):949-55. PubMed ID: 18959608 [Abstract] [Full Text] [Related]
53. The many faces of hepatitis C: liver disease and type 2 diabetes. Milner KL, Chisholm D, George J. Hepatology; 2009 Sep; 50(3):668-70. PubMed ID: 19670421 [No Abstract] [Full Text] [Related]
56. Differences in cardiovascular risk profile based on relationship between post-load plasma glucose and fasting plasma levels. Succurro E, Marini MA, Grembiale A, Lugarà M, Andreozzi F, Sciacqua A, Hribal ML, Lauro R, Perticone F, Sesti G. Diabetes Metab Res Rev; 2009 May; 25(4):351-6. PubMed ID: 19319930 [Abstract] [Full Text] [Related]
58. Leisure time physical activity in individuals with screen-detected type 2 diabetes compared to those with known type 2 diabetes. Karjalainen J, Peltonen M, Vanhala M, Korpi-Hyövälti E, Puolijoki H, Saltevo J, Oksa H, Saaristo T, Tuomilehto J, Kujala UM. Diabetes Res Clin Pract; 2008 Jul; 81(1):110-6. PubMed ID: 18433914 [Abstract] [Full Text] [Related]